Star Individuals
Band 1
Band 3
About
Provided by Eileen M McMahon
Practice Areas
Eileen is a co-founder of the intellectual property and food and drug regulatory practices at Torys. She represents the entire spectrum of companies on regulatory clearance and intellectual property protection of products. Across sectors—including life sciences (pharmaceuticals, medical devices, natural health products), agribusiness, consumer products and more—Eileen helps clients identify, protect and leverage IP and regulatory assets, obtain and maintain market exclusivity, handle high-risk situations (corrective actions, recalls, regulatory orders), and navigate the impact of current and proposed laws on clients’ ability to sell products. Eileen also has market-leading experience with patented medicines and oversight of Canada’s Patented Medicines Prices Review Board (PMPRB). Eileen also represents investors and companies looking to finance or invest in companies with intellectual property and regulatory assets, as well as companies looking to acquire or divest such assets.
Eileen’s unique experience and strong market presence are well recognized: in addition to her Band 1 ranking in Intellectual Property by Chambers & Partners, Eileen is the only Canadian lawyer to be recognized as a Star Individual in Life Sciences. Managing IP regards her as one of the world’s top 250 women in IP, and The Legal 500 recognizes her as one of Canada’s leading lawyers in intellectual property.
Eileen is a registered patent and trademark agent in the United States and Canada. She is also a Certified Licensing Professional of the Licensing Executive Society (LES).
Eileen is a former member of Torys’ Executive Committee.
Chambers Review
Canada
Eileen McMahon enjoys a reputation as one of Canada's foremost life sciences lawyers and is considered a go-to expert by many major pharmaceutical companies. She assists with product regulations and licensing, as well as intellectual property. She is based in Toronto, from where she leads Torys' IP and food and drug regulatory practices.
Eileen McMahon has cultivated an outstanding reputation in the life sciences sector, with a knowledge base spanning issues from patent filing and prosecution to regulatory compliance and pricing.
Eileen McMahon draws upon her wealth of experience handling intellectual property and regulatory matters to provide support to cannabis sector clients. Based in Toronto, she is the chair of the law firm's IP and food and drug regulatory practices.
Strengths
Provided by Chambers
"Eileen is a leading voice in Canadian pharmaceutical IP. She is a wonderful resource and a pleasure to work with."
"She is a great partner and provides value for my team."
"Eileen is unmatched in terms of industry experience and insight into the pharmaceutical environment."
"Eileen is at the top of her field and is an approachable lawyer, leader and mentor."
"Eileen is a legal giant in Canada, for healthcare especially, and a go-to for any tricky issues. Her depth of expertise and market knowledge is unmatched."
"Eileen McMahon is one of the most highly regarded and respected lawyers in the life sciences and pharmaceutical landscapes in Canada. She is highly experienced and a trusted partner."
"Eileen is a superb attorney; she is very experienced and knowledgeable."
"Eileen is a leading voice in Canadian pharmaceutical IP. She is a wonderful resource and a pleasure to work with."
"She is a great partner and provides value for my team."
"Eileen is unmatched in terms of industry experience and insight into the pharmaceutical environment."
"Eileen is at the top of her field and is an approachable lawyer, leader and mentor."
"Eileen is a legal giant in Canada, for healthcare especially, and a go-to for any tricky issues. Her depth of expertise and market knowledge is unmatched."
"Eileen McMahon is one of the most highly regarded and respected lawyers in the life sciences and pharmaceutical landscapes in Canada. She is highly experienced and a trusted partner."
"Eileen is a superb attorney; she is very experienced and knowledgeable."
Articles, highlights and press releases
1 item provided by Torys LLP
Rewiring the supply chain: how the pandemic is shaping government procurement
COVID-19 has long-term implications for how governments think about procurement. Obtaining vaccines & critical supplies was no easy feat during the pandemic. This article examines domestic production, foreign procurement and how the global supply chain is shaping public policy goals and objectives.
Rewiring the supply chain: how the pandemic is shaping government procurement
COVID-19 has long-term implications for how governments think about procurement. Obtaining vaccines & critical supplies was no easy feat during the pandemic. This article examines domestic production, foreign procurement and how the global supply chain is shaping public policy goals and objectives.
Discover other Lawyers at
Torys LLP
Alberta
Atlantic Canada
Nationwide - Canada
